Sie sind hier: Startseite > News > Nature Medicine Publication Elucidating Probiodrug´s New Treatment Paradigm for Alzheimer’s disease

NEWS.

 

Nature Medicine Publication Elucidating Probiodrug´s New Treatment Paradigm for Alzheimer’s disease

Halle/Saale, September 29th, 2008

Probiodrug AG (Probiodrug), a developer of small molecule inhibitors for the treatment of inflammatory and neurodegenerative diseases, today announced the publication of in vivo data in Nature Medicine supporting the finding that inhibition of the enzyme Glutam(in)yl Cyclase (QC) can be considered as a potentially causative new treatment of neurodegeneration in Alzheimer’s Disease (AD).
Quelle: http://www.probiodrug.de/index.php?id=28&tx_ttnews[tt_news]=46&cHash=ef0f3c5279

For more Information click here.

Contact
Weinbergweg 22
06120 Halle/Saale
Germany

Phone: +49 345 5559900
Telefax: +49 345 5559901
E-Mail: info@probiodrug.de
 

Artikelaktionen